Role of free radicals and antioxidants in the pathogenesis of the inflammatory periodontal diseases

Journal of Clinical Pathology - Clinical Molecular Pathology

Volumn 49, Issue 5, 1996, Pages

  Chappie, Iain L C ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b Dental School   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; FREE RADICAL;

HUMAN; NEUTROPHIL; PERIODONTAL DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 0029797513     PISSN: 13552910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (94)

1. Todd JE, Lader D. 1988 Adult dental health survey of the United Kingdom. London: Office of Population Censuses and Surveys, Social Division 1988:131-44.
2. Löe H, Theilade E, Jensen SB. Experimental gingivitis in man. J Periodontol 1965;35:177-87.
3. Chappie ILC. The initiation and progression of periodontal disease. In: Heasman PA, Milieu DT, eds. The periodontal tissues and orthodontics in health and disease. Oxford: Oxford University Press, 1996:33-72.
4. Chappie ILC, Cross IA, Glenwright HD, Matthews JB. Calibration and reliability of the periotron 6000 for individual gingival crevicular fluid samples. J Periodontal Res 1995;30:73-9.
5. Charon JA, Mergenhagen SE, Gallin JI. Gingivitis and oral ulcération in patients with neutrophil destruction. J Oral Pathol 1985;14:150-5.
6. Delgado W, Calderon R. Acatalasia in two Peruvian siblings. J Oral Pathol 19 79 ;8:3 5 8-68.
7. Cohen SG, Greenberg MS. Chronic oral herpes simplex virus infection in immunocompromised patients. Oral Surg OmlMed Oral Pathol 1985;59:465-71.
8. Asman B, Engstrom PE, Olsson T, Bergstrom K. Increased luminol enhanced chemiluminescence from peripheral granulocytes in juvenile periodontitis. Scand J Dental Res 1984;92:218-23.
9. Henry ÇA, Winfold TE, Laohapund P, Yotnuengnit P. Neutrophil chemiluminescence and opsonic activities of young people with periodontitis in Thailand. Arch Oral Biol 1984; 29:623-7.
10. Shapira L, Borinski R, Sela MN, Soskolne A. Superoxide formation and chemiluminescence of peripheral polymorphonuclear leukocytes in rapidly progressive periodontitis patients. J Clin Periodontol 1991;18:44-8.
11. Offenbacher S. Clinical trials of host modulation therapy. Proceedings of Joint Symposium on Clinical Trials Design and Analysis in Periodontics. National Institute of Health, Bethesda, Washington DC, USA. February 1996;1:37.
12. Halliwell B. Reactive oxygen species in living systems: source, biochemistry, and role in human disease. AmJMed 1991;91(Suppl 3C):3C14S-22S.
13. Halliwell B, Gutteridge JMC. The antioxidants of human extracellular fluids. Arch Bwchem Biophys 1990;280:1-8.
14. Bartold PM, Wiebkin OW, Thonard JC. The effect of oxygen-derived free radicals on gingival proteoglycans and hyâluronic acid. J Periodontal Res 1984;19:390-400.
15. Varani J, Fligiel SEG, Till GO, Kunkel RG, Ryan US, Ward PA. Pulmonary endothelial cell killing by human neutrophils: possible involvement of hydroxyl radical. Lab Invest 1985;53:656-63.
16. Staal FJT, Roederer M, Herzenberg LA, Herzenberg LA. Intracellular thiols regulate activation of nuclear factor KB and transcription of human immunodeficiency virus. Proc NatlAcadSci USA 1990;87:9943-7.
17. Pryor WA. Oxy-radicals and related species: their formation, lifetimes, and reactions. Annu Rev Physiol 1986;48:657-67.
18. Fridovich I. Superoxide dismutase: an adaptation to a paramangetic gas. J Biol Chem 1989;264:7761-4.
19. Imlay JA, Fridovich I. Assays of metabolic Superoxide production in Escherichia coli. J Biol Chem 1991;266: 6957-65.
20. Crystal RG. Oxidants and respiratory tract epithelial injury: pathogenesis and strategies for therapeutic intervention. /4wJM1991;91(Suppl3C):3C39S-44S.
21. Curnette JT, Babior BM. Chronic granulomatous disease. Adv Hum Genet 1987;16:229-45.
22. Maly FE. The B-lymphocyte: a newly-recognised source of reactive oxygen species with immunoregulatory potential. Free Radie Res Commun 1990;8:143-8.
23. Key LL, Wolfe WC, Gundberg CM, Ries WL. Superoxide and bone résorption. Bone 1994;15:431-6.
24. McCord JM, Fridovich I. Superoxide dismutase an enzyme function for erythrocuprein (hemocuprein). J Biol Chem 1969;244:6049-55.
25. Sutton HC, Winterbourn CC. On the participation of higher oxygénation states of iron and copper in Fenton reactions. Free Radie Biol Med 1989;6:53-60.
26. Stocks J, Gutteridge JMC, Sharpe RF, Dormandy TL. The inhibition of lipid autoxidation by human serum and its relationship to serum proteins and alpha tocopherol. Clin Sei 1974;47:223-33.
27. Gutteridge JMC, Patterson SK, Segal AW, Halliwell B. Inhibition of lipid peroxidation by the iron-binding protein lactoferrm. Bwchem J 1981;199:259-61.
28. Gutteridge JMC, Stocks J. Caeruloplasmin: physiological and pathological perspectives. CRC Grit Rev Clin Lab Sei 1981;14:257-329.
29. Gutteridge JMC. Antioxidant properties of the proteins caeruloplasmin, albumin and transferrin. A study of their activity in serum and synovial fluid from patients with rheumatoid arthritis. Biochim BiophysActa 1986;869:119-27.
30. Gutteridge JMC. The antioxidant activity of haptoglobin towards haemoglobin-stimulated lipid peroxidation. Biochim BiophysActa 1987;917:219-23.
31. Esterbauer H, Zollner H, Schaur RJ. Hydroxyalkenals: cytotoxic products of lipid peroxidation. ISI Atlas Sei Biochem 1988;1:311-15.
32. Morrow JD, Hill KE, Burke RF, Nammour TM, Bads KF, Roberts LJII. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalysed mechanism. Proc Natl Acad Sei USA 1990;87:9383-7.
33. Morrow JD, Roberts LJ II. Quantification of noncyclooxygenase derived prostanoids as a marker of oxidative stress. Free Radie BiolMed 1991;10:195-200.
34. Pruijn FB, Bast A. Effects of free radicals on hormonally and non-hormonally regulated calcium homeostasis in rat liver microsomes and hepatocytes. Adv Biosci 1989;76:83-97.
35. Crompton M, Costi A, Hayat L. Evidence for the presence of reversible Ca2+ dependent pore activated by oxidative stress in heart mitochondria. Biochem J 1987;245:915-18.
36. Dean RT, Thomas SM,Garner A. Free-radical-mediated fragmentation of monoamine oxidase in the mitochondrial membrane. Role of lipid radicals. Biochem J 1986;240:489-94.
37. Cooper B, Creeth JM, Donald ASR. Studies of the limited degradation of mucous glycoproteins. The mechanism of peroxide reaction. Biochem J 1985;228:615-26.
38. Breimer LH. Repair of DNA damage induced by reactive oxygen species. Free Radie Res Commun 1991;14:159-71.
39. Jackson JH, Gajewski E, Schraufstatter IU, Hyslop PA, Fuciarelli AE, Cochrane CG, Dizdaroglu M. Damage to the bases in DNA induced by stimulated neutrophils. J Clin Invest 198884:1644-9.
40. Aruoma OL, Halliwell B, Dizdaroglu M. Iron-dependent modification of bases in DNA by the Superoxide radical generating system hypoxanthine/xanthine oxidase. J Biol Chem 1989;264:13024-8.
41. Cochrane C. Cellular injury by oxidants. Am J Med 1991;91(Suppl 3C):3C23S-30S.
42. Halliwell B. How to characterise biological antioxidants. Free Radie Res Commun 1990;9:1-31.
43. Halliwell B, Gutteridge JMC. In: Free radicals in biology and medicine. 2nd edn. Oxford: Clarendon Press, 1989.
44. Halliwell B, Gutteridge JMC, Cross CE. Free radicals, antioxidants, and human disease: where are we now? J Lab Clin MeJ1992;119:598-620.
45. Schreck R, Rieber P, Baeuerle A. Reactive oxygen intermediates as apparently widely-used messengers in the activation of the NF-KB transcription factor and HIV-1. EMBO J 1991;10:2247-58.
46. Baeurele PA, Baltimore D. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-KB transcription factor. Cell 1988;53:211-17.
47. Liberman TO, Baltimore D. Activation of interleukin-6 gene expression through NFKB transcription factor. Mol Cell Biol 199010:2327-34.
48. Osborn L, Kunkel S, Nabel G. Tumour necrosis factor a and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of nuclear factor KB. Proc Natl Acad Sei USA 1989;86:2236-40.
49. Shirikawa F, Chedid M, Suttles J, Plooak PA, Mizel SB. Interleukin 1 and cyclic AMP induce K immunoglobulin light-chain expression via NF-K-like DNA-binding protein. Mol Cell Biol 1989;9:959-64.
50. Meichle A, Schütze S, Hanzel G, Brunsing D, Kronke M. Protein kinase C-independent activation of nuclear factor kappa B by tumour necrosis factor. J Biol Chem 1990;26S: 8339-43.
51. Vincenti MP, Burrell TA,Taffet SM. Regulation of NFKB activity in murine macrophages: effect of bacterial lipopolysaccharide and phorbol ester. J Cell Physiol 1992;150:204-13.
52. Gutteridge JMC. Biological origin of free radicals, and mechanisms of antioxidant protection. Chemico-Biological Interactions 1994;91:133-40.
53. Weiss SS. Tissue destruction by neutrophils. N EnglJ Med 1990;320:365-76.
54. Schraufstatter IU, Browne K, Harris A, Hyslop PA, Jackson JH, Quehenberger O, Cochrane C. Mechanisms of hypochlorite (HOC1) injury of target cells. J Clin Invest 199085:554-62.
55. Suomalainen K, Sorsa T, Lindy O, Saari H, Konttinen YT, Uitto VJ. Hypochlorous acid induced activation of human neutrophil and gingival crevicular fluid collagenase can be inhibited by ascorbate. Scand J Dental Res 1991;99:39705.
56. Moore S, Calder KAC, Miller NJ, Rice-Evans A. Antioxidant activity of saliva and periodontal disease. Free Radie Res 1994;21:417-25.
57. Chappie ILC, Thorpe GHG, Mason GI, Matthews JB. Low molecular weight thiol antioxidant activity in oral fluids. In: Szalay A, Kricka P, eds. Bioluminescence and chemiluminescence. Chichester: John Wiley and Sons, 1997.
58. Krinsky NI. Antioxidant functions of carotenoids. Free Radie BiolMed 1989;7:617-35.
59. Meyle J, Kapitza K. Assay of ascorbic acid in human crevicular fluid from clinically healthy gingival sites by high-performance liquid chromatography. Arch Oral Biol 1990;35:319-23.
60. Lunée J, Blake DR. The determination of dehydroascorbic acid and ascorbic acid in the serum and synovial fluid of patients with rheumatoid arthritis (RA). Free Radie Res Commun 1981;l:31-9.
61. Leggott PJ, Robertson PB, Jacob RA, Zambon JJ, Walsh M, Armitage GC. Effects of ascorbic acid depletion and supplementation on periodontal health and subgingival microflora in humans. J Dental Res 1991;70:1531-6.
62. Jacob RA, Omaye ST, Skala JH, Leggott PJ, Rothman DL, Murray PA. Experimental vitamin C depletion and supplementation in young men. Nutrient interactions and dental health effects. Ann NYAcad Sei 1987;498:333-46.
63. Vaananen MK, Markkanen HA, Tuovinen VJ, Kullaa AM, Karinpaa AM, Kumpusalo EA. Periodontal health related to plasma ascorbic acid. Proc Finnish Dental Sod 993;89:51-9.
64. Esterbauer H, Striegl G, Puhl H, Oberreither S, Rotheneder M, El-Saadani M, Jürgens G. The role of vitamin E and carotenoids in preventing oxidation of low density lipoproteins. Ann NYAcad Sei 1989;570:254~67.
65. Niki E. Lipid antioxidants: how they may act in biological systems. BrJ Cancer 1987;55:157-7.
66. Slade EW Jr, Bartuska D, Rose LE, Cohen DW. Vitamin E and periodontal disease. J Periodontol 1976;47:352-4.
67. Cerna H, Fiala B, Fingerova H, Pohanka E, Szwarcon A. Contribution to indication of total therapy with vitamin E in chronic periodontal disease (pilot study). Acta Universitatis Palackianae Olomucensis Facultatis Medicae 1984;107: 167-70.
68. Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defence in humans against oxidantand radical-caused ageing and cancer: a hypothesis. Proc Natl Acad Sei USA 1981;78:6858-62.
69. Grootveld M, Halliwell B. Measurement of allantoin and uric acid in human body fluids. A potential index of free-radicals in vivo? Biochem J 1987;243:803-8.
70. Aruoma OL, Halliwell B, Dizdaroglu M. Iron irondependent modification of bases in DNA by the Superoxide radical generating system hypoxanthine/xanthine oxidase. J BiolChem 1989;264:13024-8.
71. Fanger MW, Hart DA, Wells JV, Nisonoff A. Enhancement by reducing agents of the transformation of human and rabbit peripheral lymphocytes. J Immunol 1970; 105:1043-5.
72. Droge W, Eck HP, Näher H, Pekar U, Daniel V. Abnormal amino acid concentrations in the blood of patients with acquired immunodeficiency syndrome (AIDS) may contribute to the immunological defect. Biological Chemistry Hoppe-Seyler 1988;369:143-8.
73. Liang GM, Lee N, Cattell D, Liang SM. Glutathione regulates interleukin-2 activity on cytotoxic T-cells. J Biol Chem 1989;264:13519-23.
74. Suthanthiran M, Anderson ME, Sharma VK, Meister A. Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated by the CD2 and CD3 antigens. Proc Natl Acad Sei USA 1990;87:3343-7.
75. Morris PE, Bernard GR. Significance of glutathione in lung disease and implications for therapy. Am J Med Sei 1994;307:119-27.
76. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR. Stimulation of bone résorption and inhibition of bone formation in vitro by human tumour necrosis factor. Nature 1986;319:516-18.
77. Amano S, Hanazawa S, Hirose K, Ohmori Y, Kitano S. Stimulatory effect on bone résorption by interleukin-1-like cytokine produced by an osteoblast-rich population of mouse calvarial cells. Calific Tissue Int 1988;43:88-91.
78. Littlewood A, Aarden L, Evans D, Russell R, Gowen M. Human osteoblast-like cells to not respond to interleukin-6. J Bone Miner Res 1991;6:141-8.
79. Schroeder J-M, Mrowietz U, Morita E, Christophers E. Purification and partial biochemical characterisation of a human monocyte-derived, neutrophil activating peptide that lacks interleukin-1 activity. J Immunol 1987; 139:3474-83.
80. Bernard GR. N-acetylcysteine in experimental and clinical acute lung injury./îwJAfed 1991;91(Suppl3C):54S-59S.
81. Cantin A, North SL, Hubbard RC, Crystal RG. Normal alveolar epithelial lining fluid contains high levels of glutathione. J Appl Physioll987;63:152-7.
82. Pacht ER, Timerman AP, Lykens MG, Merola AJ. Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome. Chest 1991;100:1397-403.
83. Persson S, Edlund M-B, Claesson R, Carlsson J. The formation of hydrogen sulfide and methyl mercaptan by oral bacteria. Oral Microbiol Immunol 1990;5:195-201.
84. van der Hoeven JS, van den Kieboom CWA, Schaeken MJM. Sulfate-reducing bacteria in the periodontal pocket. Oral Microbiol Immunol 1995;10:288-90.
85. Carlsson J, Larsen JT, Edlund E-D. Peptostreptococcus micros has a uniquely high capacity to form hydrogen sulfide from glutathione. Oral Microbiol Immunol 1993;8:42-5.
86. Carlsson J, Larsen JT, Edlund, E-D. Utilization of glutathione (L-y-glutamyl-L-cysteinylglycine) by Fusobacterium nucleatum subspecies nucleatum. Oral Microbiol Immunol 1994;9:297-300.
87. Nicholls P, Kim KJ. Sulfide as an inhibitor and electron donor for the cytochrome c oxidase system. Can J Biochem 1982;60:613-23.
88. Claesson R, Granlund-Edstedt M, Persson S, Carlsson J. Activity of polymorphonuclear leukocytes in the presence of sulfide. Infect Immun 1989;57:2776-81.
89. Wayner DD, Burton GW, Ingold KU, Barclay LR, Locke SJ. The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochim Biophys Acta 1987;924:408-19.
90. Whitehead TP, Thorpe GHG, Maxwell SRJ. Enhanced chemiluminescent assay for antioxidant capacity in biological fluids. Anal Chim Acta 1992;266:265-77.
91. Guarnieri C, Zucchelli G, Bernardi F, Scheda M, Valentini AF, Calandriello M. Enhanced Superoxide production with no change of the antioxidant activity in gingival fluid of patients with adult periodontitis. Free Rad Res Commun 1991;15:11-16.
92. Chappie I, Eftimiadi C, Dibart S, Socransky S, Matthews J. Low molecular weight antioxidant activity in gingival crevicular fluid (GCF). J Dental Res 1996;75:49.
93. Marucha PT, Zeff RA, Kreutzer DL. Regulation of IL-1β gene expression in human peripheral blood PMN. J Penodontal Res 1991 ;26:264-7.
94. Page RC, Schroeder HE. Pathogenesis of inflammatory periodontal disaese-a summary of current work. Lab Invest 1976;34:235-48.